DECOY THERAPEUTICS INC (DCOY)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$2.69-6.60%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · DCOY
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||
| Revenues | — | — | — | — | 0.0 | 1.8 | 5.2 | 3.5 | 2.0 | 1.3 | 1.0 | 0.1 | — |
| Total Revenues | — | — | — | — | — | — | — | — | — | 1.3 | 1.0 | — | — |
| Cost of Revenues | — | — | — | — | — | — | — | — | 0.4 | — | — | — | — |
| Operating Expenses & Income | |||||||||||||
| R&D Expenses | 2.2 | 0.4 | 0.8 | 7.2 | 15.8 | 8.5 | 6.9 | 4.0 | 1.3 | 17.0 | 20.4 | 12.7 | — |
| Operating Income | (14.8) | (12.6) | (5.7) | (12.9) | (31.8) | (12.8) | (7.8) | (8.3) | (1.7) | (34.7) | (39.9) | (29.2) | — |
| Earnings from Continuing Operations | |||||||||||||
| EBT, Incl. Unusual Items | — | — | — | — | — | — | — | — | — | — | — | (29.2) | — |
| Income Tax Expense | — | — | — | — | — | — | — | 0.0 | — | — | — | — | — |
| Net Income | |||||||||||||
| Net Income | 10.6 | (12.5) | (5.6) | 12.5 | (31.6) | (12.8) | (7.4) | (6.9) | (1.7) | (34.4) | (39.5) | (29.1) | — |
| Per Share | |||||||||||||
| Basic EPS | 19.91 | (129.10) | (5.79) | (30.74) | (14.88) | (7.72) | (0.50) | — | — | — | — | — | — |
| Diluted EPS | 19.91 | (129.10) | (5.79) | (30.74) | (14.88) | (7.72) | (0.50) | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 0.5 | 0.1 | 1.0 | 0.4 | 2.1 | 1.7 | 15.6 | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 0.5 | 0.1 | 1.0 | 0.4 | 2.1 | 1.7 | 15.6 | — | — | — | — | — | — |
| Supplemental | |||||||||||||
| EBITDA | — | (12.6) | (5.7) | (12.9) | (31.8) | (12.8) | (7.8) | (8.1) | — | — | — | — | — |
| EBIT | (14.8) | (12.6) | (5.7) | (12.9) | (31.8) | (12.8) | (7.8) | (8.3) | (1.7) | (34.7) | (39.9) | (29.2) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.